Biopharmaceutical company launching breakthrough metabolic disease therapy

Early phase clinical results suggest potential to alter the treatment paradigm, though requires significant education and behavioral changes

Strong clinical foundation, with marketing elements (e.g., distribution, brand identity, product positioning, selling messages, etc.) still to be defined

Exploratory physician research to inform brand strategy development

Focused ideation to develop an array of testable positioning and naming directions

Working sessions with clinical thought leaders to link emerging clinical data and practices with positioning and messaging alternatives

Qualitative and quantitative pharmaceutical market research validation, across pharmacists, primary care and physician specialists

Alignment of brand vision across organization to drive supporting activities (e.g., clinical studies, advisory group agenda, investor and distribution partnership presentations, etc.)

Recommended brand positioning, messaging, brand name and logo alternatives to “bring the brand to life”